Cell Therapeutics stock rebounded more than 10 percent Thursday to close at $1.15, after news that it secured a loan of up to $15 million with a Palo Alto-based finance company.
It was a boost for the stock price, which hit an all-time low of $1.02 on Monday (accounting for reverse stock splits), following filings showing that 10 top executives had sold more than 500,000 shares last week.
A Cell Therapeutics spokeswoman explained the executives sold stock to pay the company’s taxes.
Hercules…
Cell Therapeutics stock rebounded more than 10 percent Thursday to close at $1.15, after news that it secured a loan of up to $15 million with a Palo Alto-based finance company.
It was a boost for the stock price, which hit an all-time low of $1.02 on Monday (accounting for reverse stock splits), following filings showing that 10 top executives had sold more than 500,000 shares last week.
A Cell Therapeutics spokeswoman explained the executives sold stock to pay the company’s taxes.
Hercules…